Research Article
Plasma Levels of Soluble HLA-E and HLA-F at Diagnosis May Predict Overall Survival of Neuroblastoma Patients
Table 2
Correlations between serum biomarkers and clinical parameters.
| | Sex | N-myc amplification | Age at diagnosis | Stage | | F | M | No | Yes | <18 m | >18 m | 1–3 | 4 |
| Chromogranin | | | | | | | | | Below 6.16 pg/mL | 18 | 39 | 40 | 18 | 30 | 28 | 33 | 24 | Above 6.16 pg/mL | 17a | 10 | 17 | 9 | 11 | 15 | 9 | 18 | HLA-E | | | | | | | | | Below 0.216 AU/mL | 20 | 23 | 31 | 10 | 17 | 30 | 12 | 35 | Above 0.216 AU/mL | 15 | 26 | 33 | 10 | 24a | 13 | 35a | 2 | HLA-F | | | | | | | | | Below 0.995 AU/mL | 14 | 34 | 40 | 14 | 20 | 31 | 18 | 33 | Above 0.995 AU/mL | 14 | 22 | 18 | 12 | 21a | 12 | 29a | 4 | Below 0.445 AU/mL | 10 | 14 | 17 | 6 | 7 | 17 | 2 | 22 | Above 0.445 AU/mL | 22 | 38 | 41 | 20 | 34a | 26 | 45a | 15 |
|
|
P < 0.05 (Fisher’s exact test).
|